Praxis Precision Medicines (PRAX) Tops Q3 EPS by 11c

Praxis Precision Medicines (NASDAQ: PRAX) reported Q3 EPS of ($3.36), $0.11 better than the analyst estimate of ($3.47).

For earnings history and earnings-related data on Praxis Precision Medicines (PRAX) click here.

You May Also Be Interested In

• UGI shares spike on reported KKR bid for the company
• Active options: MSFT PLTR SNDK CRWV AVGO NKE GOOGL WOLF MSTR NBIS
• EyePoint Pharmaceuticals (EYPT) call put ratio 1 call to 2.7 puts as share price down 2.2%